<DOC>
	<DOCNO>NCT00388115</DOCNO>
	<brief_summary>RATIONALE : Radiofrequency ablation use high-frequency , electric current kill tumor cell . Giving radiofrequency ablation surgery may make tumor small reduce amount normal tissue need remove . PURPOSE : This clinical trial study well radiofrequency ablation follow surgery work treat patient early invasive breast cancer ductal carcinoma situ .</brief_summary>
	<brief_title>Radiofrequency Ablation Treating Patients With Early Invasive Breast Cancer Ductal Carcinoma Situ</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine effectiveness radiofrequency ablation ( RFA ) , term amount tumor coagulate viable cell count , patient early invasive breast cancer low- intermediate-grade ductal carcinoma situ . Secondary - Determine size , configuration , pathological feature human breast tumor treatment RFA . - Determine whether RFA energy apply breast cancer result cancer cell death . - Determine whether tumor-free margin achieve RFA patient . - Determine rate acute toxicity skin surgery patient treat regimen . OUTLINE : This pilot study . - Pre-radiofrequency ablation ( RFA ) procedure : Patients undergo stag MRI assessment determine size tumor . Patients nonpalpable lesion must undergo placement metallic clip center tumor hook wire guide surgical excision intraoperative ultrasound imaging . Patients invasive breast cancer undergo axillary lymph node dissection sentinel lymph node biopsy ( SLNB ) axillary lymph node stag . Patients ductal carcinoma situ proceed directly RFA/resection since require axillary staging . - RFA : Patients undergo RFA comprise insertion multiple-needle electrode breast tumor direct guidance ultrasonography metallic clip place preoperatively lesion . - Surgical resection RFA area : After RFA complete , electrode remove patient undergo wide local excision residual tumor mastectomy . After completion study therapy , patient follow periodically 4 month . PROJECTED ACCRUAL : A total 30 patient accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<criteria>Females age â‰¥18 year . Core biopsy proven invasive breast cancer OR Core biopsy proven low intermediate grade DCIS . Tumor less equal 2.0 cm diameter . No prior surgical treatment breast cancer within 30 day . Life expectancy &gt; 10 year , include diagnosis cancer . ECOG performance status 02 . Informed consent give . Multifocal invasive breast cancer patient eligible . All tumor palpable visualized USS treat . Male subject . Ages &lt; 18 year . Breast tumor &gt; 2.0 cm diameter . Evidence distant metastatic disease . Evidence diffuse calcification suggestive extensive multifocal DCIS . High grade DCIS presence comedonecrosis lesion associate invasive breast cancer , would go undetected lesion entirely destroy RF ablation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>ductal breast carcinoma situ</keyword>
	<keyword>stage I breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>breast cancer situ</keyword>
</DOC>